|
0
|
|
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.
(nejm.org)
|
Cohn DM
…
Banerji A
New England Journal of Medicine
2026-06-13
|
#crispr
#hereditary angioedema
#clinical trial
#genome editing
|
|
0
|
|
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).
(linkinghub.elsevier.com)
|
Neuen BL
…
Agarwal R
The Lancet
2026-06-13
|
#ckd
#meta-analysis
#clinical trial
#kidney disease
#cardiovascular
|
|
0
|
|
Atrasentan in patients with IgA nephropathy (ALIGN): final 2.5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Heerspink HJL
…
Barratt J
The Lancet
2026-06-13
|
#nephropathy
#proteinuria
#clinical trial
#kidney disease
#endothelin antagonist
|
|
0
|
|
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.
(nejm.org)
|
Mina R
…
Voorhees PM
New England Journal of Medicine
2026-06-13
|
#immunotherapy
#myeloma
#bispecific
#clinical trial
#antibody
|
|
0
|
|
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
(linkinghub.elsevier.com)
|
Bajaj HS
…
Bartee A
The Lancet
2026-06-13
|
#diabetes
#clinical trial
#obesity
#metabolism
#pharmacology
|
|
0
|
|
Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial.
(linkinghub.elsevier.com)
|
Dimopoulos MA
…
Richardson PG
The Lancet
2026-06-14
|
#immunomodulation
#multiple myeloma
#clinical trial
#amr
|
|
0
|
|
Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection.
(academic.oup.com)
|
Byrne S
…
Uehara T
Clinical Infectious Diseases
2026-06-15
|
#antiviral
#clinical trial
#rsv
#infection
#virulence
|
|
0
|
|
Intravenous human umbilical cord-derived mesenchymal stem cell transplantation for ischemic stroke (MERIT): A phase 1 trial.
(linkinghub.elsevier.com)
|
Cui L
…
Hao J
Cell Reports Medicine
2026-06-16
|
#stroke
#stem cell
#transplantation
#immunology
#clinical trial
|
|
0
|
|
Pro/synbiotics reduce systemic inflammation and improve gut health in Kenyan infants: An open label, randomized, 4-arm, phase II trial.
(linkinghub.elsevier.com)
|
Otiti MI
…
Allen S
Cell Reports Medicine
2026-06-16
|
#probiotic
#inflammation
#microbiome
#clinical trial
#dysbiosis
|
|
0
|
|
Trial-ready external controls for gene therapy: The MATCH cohort in maple syrup urine disease.
(linkinghub.elsevier.com)
|
Brigatti KW
…
Strauss KA
Cell Reports Medicine
2026-06-16
|
#gene therapy
#metabolic disorder
#natural history
#clinical trial
#external controls
|
|
0
|
|
Patellar resurfacing in total knee replacement: 20-year clinical and economic results of a large multicentre, randomised controlled trial in the UK.
(linkinghub.elsevier.com)
|
Murray DW
…
Campbell MK
The Lancet
2026-06-17
|
#arthroplasty
#clinical trial
#cost-effectiveness
#orthopedics
|
|
0
|
|
Phase I dose-ascending, safety, and pharmacokinetics study of APC148, a novel metallo-beta-lactamase inhibitor, in healthy volunteers.
(journals.asm.org)
|
Bolstad B
…
Rongved P
Antimicrobial Agents and Chemotherapy
2026-06-17
|
#pharmacokinetics
#amr
#clinical trial
#infection
|
|
0
|
|
Prehospital Whole Blood in Traumatic Hemorrhage - A Randomized Controlled Trial.
(nejm.org)
|
Smith JE
…
Green L
New England Journal of Medicine
2026-06-18
|
#hemorrhage
#transfusion
#trauma
#clinical trial
|
|
0
|
|
Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).
(bmj.com)
|
Jackson TL
…
Reeves BC
BMJ
2026-06-18
|
#radiotherapy
#amd
#clinical trial
#angiogenesis
|
|
0
|
|
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
(nejm.org)
|
Lee TC
…
Tong SYC
New England Journal of Medicine
2026-06-18
|
#bacteremia
#infection
#amr
#clinical trial
|
|
0
|
|
Safety and efficacy of GZR18, a long-acting GLP-1 analog, in Chinese patients with type 2 diabetes: A randomized, double-blind, phase 1b/2a trial.
(linkinghub.elsevier.com)
|
Liu M
…
Chen W
Cell Reports Medicine
2026-06-19
|
#diabetes
#drug development
#clinical trial
#metabolism
|
|
0
|
|
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Aroda VR
…
Rosenstock J
The Lancet
2026-06-20
|
#diabetes
#clinical trial
#drug development
#metabolism
|
|
0
|
|
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study.
(linkinghub.elsevier.com)
|
Shen L
…
Ji J
The Lancet
2026-06-20
|
#immunotherapy
#cancer
#chemotherapy
#clinical trial
#gastric
|
|
0
|
|
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial.
(linkinghub.elsevier.com)
|
Davies MJ
…
Sjostrom CD
The Lancet
2026-06-20
|
#obesity
#glp-1
#clinical trial
#pharmacotherapy
#metabolic syndrome
|
|
0
|
|
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Lenz G
…
Vitolo U
The Lancet
2026-06-20
|
#antibody
#lymphoma
#immunotherapy
#clinical trial
#chemotherapy
|